Would you like to help cultivate the next generation of cardiology leaders? If so, we hope you’ll consider making a contribution in celebration of the annual Hurst/Logue/Wenger Cardiovascular Reception on March 18. Gifts to the Emory Cardiology Training Fund enable cardiology trainees to attend national academic conferences; support innovative educational programs and research; and help to fund events, retreats, and other resources that enhance the overall experience of our trainees. Your generous donations help to augment learning experiences, improve teaching and presentation skills, and provide opportunities for networking and collaboration.
Cardiovascular Fellowship Program Director Robbie Williams commented, “Over the past two years, these donations have provided support for more than 35 trips to national conferences where our fellows have had abstracts accepted or were invited to present their research. Without these funds, this would not be possible for many trainees.”
Salim Hayek, MD is a past recipient of funds donated at the Hurst/Logue/Wenger Cardiovascular Reception, which he used to attend the 2016 ACC Scientific Sessions. He was also invited as faculty to ACC 2016, where he reported findings that were recently published in The New England Journal of Medicine on the novel biomarker suPar and its association with kidney disease. More recently, Dr. Hayek was awarded first prize for his oral research presentation by his peers at the ACC Georgia Chapter meeting.
Dr. Hayek’s research has advanced the ability to identify genes that cause heart disease, and he was recently recognized with Emory University’s prestigious Outstanding Postdoctoral Achievement Award. He is a member of the American College of Cardiology’s Innovation Advisory Group, and he has published more than 50 manuscripts in major journals, including The New England Journal of Medicine, Nature Genetics, and Circulation Research.
We encourage you to give to the Division of Cardiology to help shape the leaders of tomorrow, like Dr. Hayek.
More about Dr. Hayek
Dr. Salim Hayek is a cardiologist and researcher constantly striving for clinical and academic excellence. He has extensive research experience in translational science, risk prediction, biomarkers, vascular function, and stem cell therapy, among other fields. In addition to his other contributions to science, Dr. Hayek has found that a biomarker called suPAR can help identify patients at risk for kidney and cardiovascular disease, allowing for early initiation of preventive therapies. His research interests lie in the integration of novel high-throughput technologies, such as metabolomics and genomics, to implement and improve risk prediction algorithms in clinical practice, with the ultimate goal of optimizing patient care and resource allocation.
If you are interested in investing in research, clinical care, and/or education within the Emory University Division of Cardiology, please visit our website to learn how you can help.